NCCC Evaluation of MVision AI contouring software
S Warren, N Richmond MVision AI software has been under evaluation at NCCC (Newcastle upon Tyne Hospitals NHS Foundation Trust) since 28 February 2022* in…
Read more Articles
MVision: 2022 year in review
2022 came to an end. Seeing our names of customers, the number of scans and countries marked on the map, we know, we reached our…
Read more Cancer in Ireland – Raising Survival Rates
Every year, almost 45.000 people in Ireland are diagnosed with cancer, making Ireland the country with the highest cancer incidence in Europe. The 5 most…
Read more Improving Tools to Fight Glioblastoma
Background Glioblastoma multiforme represents approximately half of the cases of central nervous system malignant tumors. The median age at diagnosis is 64 years, and the…
Read more RT for Prostate Cancer: Faster and Better – Is it Possible?
Background Worldwide, more than 1 400 000 men were diagnosed with prostate cancer in 2020, and it is estimated that one third will need radiotherapy…
Read more Outcomes of SABR for Colorectal Cancer
Colorectal cancer (CRC) is one of the most common types of cancer diagnosed in the UK. About 41,000 people get cancer in the large bowel…
Read more New Year, New Patient Backlog: RT in the UK
In 2021, reports showed that cancer patients wait up to 62 days for the first dose of radiotherapy treatment in the UK. The numbers of…
Read more AI in RT 101: Prone Position
We are here to explore topics around AI in radiotherapy, share practical tips, and address questions as well as biases we with our partners come…
Read more AI in RT – Reading Package
The holiday season is a time of recharging, reflecting, and often also reading. Since our hearts pump for improving radiotherapy with AI throughout the year,…
Read more